Feature Channels:

Blood Disorders

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Stroke, Ischemic Stroke, tPA, Tpa Treatment, Door to Needle Time, Pharmacists, pharmacists and stroke, RTPA, Tissue Plasminogen Activator, recombinant tissue plasminogen activator

Having a Pharmacist at Stroke Patient's Bedside Speeds Administration of Critical Drug

In treating stroke patients, every minute counts. A drug called rtPA sometimes can stop a stroke in its tracks. Now a Loyola Medicine study has found that having a pharmacist at the patient's bedside can reduce the time it takes to administer rtPA by a median of 23.5 minutes.

Medicine

Channels:

Cancer, Dr. Robert Kyle, Dr. S. Vincent Rajkumar, Mayo Clinic, Medical Research, MGUS, Minnesota News Releases, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, New England Journal Of Medicine, news releases

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 17-Jan-2018 5:00 PM EST

Medicine

Channels:

High Cholesterol, cholesterol management, Penn Medicine, perelman school of medicine , Health Insurance, Prescription Drug Benefit, Cardiology, Cardiovascular Medicine, PCSK9 Inhibitors, Cardiovascular Quality

Insurance Company Requirements Place Heavy Administrative Burden on Physicians Seeking to Prescribe New Cholesterol-Lowering Drugs

A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke. So-called proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are self-injected medications approved for individuals with a genetic condition called familial hypercholesterolemia (FH) and those with atherosclerotic cardiovascular disease (ASCVD) who have high cholesterol despite receiving traditional statin medications and other treatments. Results of the study are published in Circulation: Cardiovascular Quality and Outcomes.

Medicine

Channels:

CAP Guideline Details HPV Testing in Head, Neck Cancers

hpv-head-neck-carcinomas-guidelines-610x304.jpg

Certain head and neck cancers that are positive for high-risk types of human papillomavirus (HPV) have a better prognosis and may need less aggressive treatment.

Medicine

Channels:

Mitochondrial Disease, Vitamins And Supplements, nutritional interventions , mitochondrial medicine, Dietary Supplements, preclinical testing, Precision Medicine

Can Vitamins and Dietary Supplements Benefit Patients with Mitochondrial Disease?

Falk_MarniRGB-10.jpg

Defects in mitochondria, the tiny structures that power our cells by functioning as biological batteries, cause an array of complex, often life-threatening disorders that can affect any and all organs and systems. In the absence of validated, effective drug treatments, patients with mitochondrial disease often take a variety of vitamins and supplements, substances that are largely unstandardized, unregulated, and unproven. A group of medical experts recommend performing systematic scientific studies to test precise nutritional interventions for patients.

Medicine

Channels:

Beta Blockers, Melanoma, Cancer, Heart Attack, Blood Pressure, Immunotherapy

Beta Blockers May Boost Immunotherapy, Help Melanoma Patients Live Longer

A common, inexpensive drug that is used to prevent heart attacks and lower blood pressure may also help melanoma patients live longer.

Medicine

Channels:

Your Disease Risk, Substance Abuse Treatments, Comparing Lung Cancer Treatments, and More in the Healthcare News Source

The latest research, features and announcements in healthcare in the Healthcare News Source

Medicine

Channels:

St. Jude Children's Research Hospital, Acute Lymphoblastic Leukemia, High-Risk Leukemia, Journal Of Clinical Oncology, Leukemia germline variations, TP53 tumor suppressor gene , second cancers

Tumor Suppressor Gene Variants Identified as Cancer ‘Double Whammy’ for Leukemia Patients

Yang.jpg

A study led by St. Jude Children’s Research Hospital found germline variations in a key tumor suppressor gene that may prompt changes in treatment and follow-up care for certain high-risk leukemia patients

Medicine

Science

Channels:

Hepatitis, Small Pox, Mummy, DNA, Sequencing, Italy, Medieval, Archaeology

DNA Analysis of Ancient Mummy, Thought to Have Smallpox, Points to Hepatitis B Infection Instead

Faccia.jpg

Scientists have sequenced the complete genome of an ancient strain of Hepatitis B, shedding new light on a pathogen that today kills nearly one million people every year. The findings, based on data extracted from the mummified remains of a small child buried in Naples, Italy, confirm the idea that HBV has existed in humans for centuries.

Medicine

Channels:

Chronic Lymphocytic Leukemia, ibrutinib, Hematology, Cancer, Leukemia

Researchers Detect a Loophole in Chronic Lymphocytic Leukemia Treatment

Tissino.jpg

A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients. The study, which will be published January 4 in the Journal of Experimental Medicine, reveals that ibrutinib has a diminished capacity to delocalize and kill tumor cells expressing an adhesive protein called CD49d, but combining ibrutinib treatment with drugs that block CD49d activation could prevent the tumor cells from sheltering in lymphoid organs.







Chat now!